UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

Lung cancer (Amsterdam, Netherlands), 2021-01, Vol.151, p.69-75

2021

Volltextzugriff (PDF)

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

Annals of oncology, 2017-11, Vol.28 (11), p.2715-2724

2017

Volltextzugriff (PDF)

Dermoscopic features in BRAF and NRAS primary cutaneous melanoma: association with peppering and blue‐white veil

Journal of the European Academy of Dermatology and Venereology, 2020-02, Vol.34 (2), p.e57-e59

2020

Volltextzugriff (PDF)

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

British journal of cancer, 2010-07, Vol.103 (2), p.165-170

2010

Volltextzugriff (PDF)

Uncommon EGFR mutations in lung adenocarcinomas: Clinical features and response to tyrosine kinase inhibitors

Annals of oncology, 2018-10, Vol.29, p.viii747-viii748

2018

Volltextzugriff (PDF)

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs

Medical oncology (Northwood, London, England), 2012-09, Vol.29 (3), p.1765-1772

2012

Volltextzugriff (PDF)

Molecular heterogeneity assessment by NGS in non-small cell lung cancer (NSCLC) harboring EGFR mutations: Results of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France study

Annals of oncology, 2018-10, Vol.29, p.viii39-viii40

2018

Volltextzugriff (PDF)

Comment on: ‘COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1’

British journal of cancer, 2015-05, Vol.112 (11), p.1836-1836

2015

Volltextzugriff (PDF)

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer

Cancer research (Chicago, Ill.), 1994-07, Vol.54 (14), p.3929-3933

1994

Volltextzugriff (PDF)

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

British journal of cancer, 2010-08, Vol.103 (4), p.482-485

2010

Volltextzugriff (PDF)

Expression of β-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases

Journal of clinical pathology, 2006-12, Vol.59 (12), p.1300-1304

2006

Volltextzugriff (PDF)

Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120ras) in bladder tumors

Cancer research (Chicago, Ill.), 1996-09, Vol.56 (18), p.4154-4158

1996

Volltextzugriff (PDF)

Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification

Oncogene, 1996-04, Vol.12 (8), p.1747-1753

1996

Volltextzugriff (PDF)

Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors

Cancer research (Chicago, Ill.), 1993-07, Vol.53 (14), p.3241-3245

1993

Volltextzugriff (PDF)

Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization

The American journal of pathology, 1995-06, Vol.146 (6), p.1341-1354

1995

Volltextzugriff (PDF)

BRAF Mutation Status in Gastrointestinal Stromal Tumors

American journal of clinical pathology, 2010, Vol.133 (1), p.141-148

2010

Volltextzugriff (PDF)

Incidence, épidémiologie des sarcomes et biologie moléculaire. Résultats préliminaires de l’étude EMS en Rhône-Alpes

Bulletin du cancer, 2010-06, Vol.97 (6), p.629-641

2010

Volltextzugriff (PDF)

Changes in cadherin‐catenin complexes in the progression of human bladder carcinoma

International journal of cancer, 1999-07, Vol.82 (1), p.70-76

1999

Volltextzugriff (PDF)

Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations

Journal of neuropathology and experimental neurology, 1998-11, Vol.57 (11), p.1061-1069

1998

Volltextzugriff (PDF)

Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region

Bulletin du cancer, 2010-06, Vol.97 (6), p.629

2010

Volltextzugriff (PDF)

Relation between aberrant α‐catenin expression and loss of E‐cadherin function in prostate cancer

International journal of cancer, 1997-08, Vol.74 (4), p.374-377

1997

Volltextzugriff (PDF)

Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen‐metabolising enzymes

International journal of cancer, 1998-10, Vol.79 (5), p.531-536

1998

Volltextzugriff (PDF)

Role of E Boxes in the Repression of E-Cadherin Expression

Biochemical and biophysical research communications, 1997-12, Vol.241 (2), p.453-458

1997

Volltextzugriff (PDF)

LBA60Uncommon EGFR mutations in lung adenocarcinomas: Clinical features and response to tyrosine kinase inhibitors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Facteurs pronostiques des cancers thyroïdiens différenciés graves : analyse préliminaire d’une cohorte prospective

Annales d'endocrinologie, 2012-09, Vol.73 (4), p.259-259

2012

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(156)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

Dermoscopic features in BRAF and NRAS primary cutaneous melanoma: association with peppering and blue‐white veil

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

Uncommon EGFR mutations in lung adenocarcinomas: Clinical features and response to tyrosine kinase inhibitors

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs

Molecular heterogeneity assessment by NGS in non-small cell lung cancer (NSCLC) harboring EGFR mutations: Results of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France study

Comment on: ‘COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1’

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

Expression of β-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases

Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120ras) in bladder tumors

Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification

Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors

Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization

BRAF Mutation Status in Gastrointestinal Stromal Tumors

Incidence, épidémiologie des sarcomes et biologie moléculaire. Résultats préliminaires de l’étude EMS en Rhône-Alpes

Changes in cadherin‐catenin complexes in the progression of human bladder carcinoma

Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations

Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region

Relation between aberrant α‐catenin expression and loss of E‐cadherin function in prostate cancer

Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen‐metabolising enzymes

Role of E Boxes in the Repression of E-Cadherin Expression

LBA60Uncommon EGFR mutations in lung adenocarcinomas: Clinical features and response to tyrosine kinase inhibitors

Facteurs pronostiques des cancers thyroïdiens différenciés graves : analyse préliminaire d’une cohorte prospective

Suchergebnisse filtern